Parameter | A. Influence of disease categories on mortality: multivariable full model | Â | B. Influence of diseases on mortality: multivariable full model | ||||||
---|---|---|---|---|---|---|---|---|---|
Odds ratio | 2.5% CI | 97.5% CI | p | Â | Odds ratio | 2.5% CI | 97.5% CI | p | |
(Intercept) | 0.00 | 0.00 | 0.00 | < 0.001 | (Intercept) | 0.00 | 0.00 | 0.00 | < 0.001 |
Cerebrovascular disorder | 8.13 | 3.83 | 17.26 | < 0.001 | Acute ischemic stroke | 3.89 | 1.85 | 8.17 | < 0.001 |
Neuromuscular disorder | 0.25 | 0.09 | 0.66 | 0.005 | Intracerebral hemorrhage | 6.14 | 2.53 | 14.89 | < 0.001 |
Encephalopathy | 1.29 | 0.65 | 2.53 | 0.466 | CIP/CIM | 0.21 | 0.08 | 0.58 | 0.003 |
Inflammatory CNS disorder | 0.79 | 0.04 | 14.73 | 0.875 | Delirium | 0.79 | 0.37 | 1.67 | 0.540 |
Epileptic disorder | 0.77 | 0.28 | 2.08 | 0.607 | Inflammatory CNS disorder | 0.81 | 0.05 | 12.20 | 0.882 |
 |  |  |  |  | Epileptic disorder | 1.01 | 0.38 | 2.69 | 0.981 |
Age (years) | 1.06 | 1.03 | 1.10 | < 0.001 |  | 1.07 | 1.04 | 1.11 | < 0.001 |
Female sex | 0.88 | 0.45 | 1.70 | 0.702 | Â | 0.73 | 0.37 | 1.44 | 0.358 |
Preexisting neurological diseases | 0.62 | 0.28 | 1.36 | 0.229 | Â | 0.59 | 0.27 | 1.27 | 0.174 |
Preexisting cardiovascular diseases | 1.24 | 0.57 | 2.72 | 0.584 | Â | 1.27 | 0.59 | 2.77 | 0.538 |
Vasopressors | 6.91 | 1.81 | 26.41 | 0.005 | Â | 6.91 | 1.84 | 25.91 | 0.004 |
Invasive ventilation | 1.07 | 0.30 | 3.78 | 0.921 | Â | 1.03 | 0.29 | 3.67 | 0.958 |
ARDSa | 1.30 | 0.54 | 3.16 | 0.556 | Â | 1.29 | 0.54 | 3.10 | 0.561 |
Acute kidney failure | 1.39 | 0.67 | 2.88 | 0.373 | Â | 1.43 | 0.69 | 2.97 | 0.331 |
Acute liver failure | 4.21 | 1.60 | 11.05 | 0.004 | Â | 4.25 | 1.63 | 11.11 | 0.003 |
Sepsis | 1.69 | 0.82 | 3.48 | 0.153 | Â | 1.41 | 0.69 | 2.87 | 0.348 |
ECMOa | 2.48 | 1.05 | 5.85 | 0.037 | Â | 2.68 | 1.15 | 6.23 | 0.022 |
pmRS (points)b | 1.37 | 1.07 | 1.75 | 0.012 | Â | 1.44 | 1.12 | 1.85 | 0.005 |
LEOSS stage of disease: complicatedc | 1.33 | 0.47 | 3.82 | 0.589 | Â | 1.14 | 0.43 | 3.06 | 0.792 |
LEOSS stage of disease: criticalc | 1.59 | 0.57 | 4.48 | 0.375 | Â | 1.46 | 0.52 | 4.10 | 0.471 |
Anticoagulant drugs on admission | 2.35 | 1.11 | 4.96 | 0.026 | Â | 2.00 | 0.95 | 4.21 | 0.068 |
Time from COVID-19 diagnosis to first neurologic deficit (days)b | 0.97 | 0.95 | 1.00 | 0.027 | Â | 0.97 | 0.95 | 1.00 | 0.025 |